{"id":"W1989803279","doi":"10.1038/sj.leu.2405087","title":"Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Renal function; Internal medicine; Creatinine; Adverse effect; Proteasome inhibitor; Urology; Phases of clinical research; Gastroenterology; Toxicity; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001359922,0.0001246504,0.0002515868,0.00005179636,0.00007803566,0.000005059023,0.00007460754,0.00003502475,0.00002235538],"category_scores_gemma":[0.0001393565,0.0000676312,0.00002375814,0.0001663309,0.0001084193,0.0000452543,0.00004793511,0.0001709013,0.00000635582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001868733,"about_ca_system_score_gemma":0.0001814361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001674154,"about_ca_topic_score_gemma":0.0001276647,"domain_scores_codex":[0.998762,0.00008005784,0.0002881844,0.0002530405,0.0004048602,0.0002118843],"domain_scores_gemma":[0.9991538,0.0002288202,0.00007725385,0.0003597856,0.00005545076,0.0001248713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04159952,0.002716901,0.9445051,0.000005904545,0.0002057699,0.0002542044,0.002306396,0.000006727345,0.00004953379,8.228761e-7,0.0002699555,0.008079195],"study_design_scores_gemma":[0.1282969,0.003255575,0.8678113,0.00007466373,0.00004245689,0.00000360837,0.0001099084,0.00009074368,0.0001447608,0.000001899017,0.000114366,0.00005380502],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979819,0.0000520283,0.000002635235,0.00008238896,0.00001106374,0.001378072,0.0001395147,0.00001217451,0.0003402282],"genre_scores_gemma":[0.9994405,0.00002961395,0.0001296874,0.00003927303,0.00003109861,0.00001810744,0.0002037999,0.00001162371,0.00009628494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08669738,"threshold_uncertainty_score":0.2757921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01932933302448729,"score_gpt":0.2877653199784997,"score_spread":0.2684359869540124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}